Since 2020, Stella has used cutting-edge and innovative biological interventions to target the physical injury caused by emotional trauma and mental health challenges like anxiety, depression, PTSD, and stress. We have treated over 8,000 patients and introduced the dual sympathetic reset protocol –– an advanced stellate ganglion block (SGB) –– created by Stella's Chief Medical Officer, Dr. Eugene Lipov, as an effective and efficient treatment in treating symptoms like depression, anxiety, PTSD, and stress. We are committed to responsible innovation, and in our first three years, Stella expanded its care model to an individualized, multimodality treatment approach, offering ketamine infusion therapy, medical & biopsychosocial assessments, integration therapy, and a DSR talk therapy curriculum in partnership with Plus by APN. Our team of board-certified physicians, advanced practice providers, and tireless advocates provide comprehensive care across 35+ USA locations, as well as in Israel and Australia. In early 2023, Stella opened a Flagship location just outside Chicago and continues to innovate by offering fast, effective, peer-reviewed breakthrough treatments for the relief people deserve.